Tag: IN.PACT AV Access
Long-term IN.PACT AV data show there is “definitely a place” for...
Matteo Tozzi (Varese, Italy) and Kate Steiner (Stevenage, UK) sat down with Vascular News at this year’s Charing Cross (CX) International Symposium (23–25 April,...
First-time presentation of IN.PACT AV Access five-year data lays paclitaxel mortality...
Andrew Holden (Auckland, New Zealand), one of the co-chairs of the Charing Cross (CX) International Symposium, presented the final five-year data on the vital...
“We know which DCB to use”—but many other questions remain in...
A first-time presentation at the 2024 Charing Cross (CX) International Symposium (23–25 April, London, UK) of five-year data from the IN.PACT AV Access study...
CX 2023: IN.PACT AV three-year subanalysis trial data show “durable” long-term...
The 2023 Charing Cross (CX) International Symposium (25–27 April, London, UK) saw a first-to-podium presentation by Andrew Holden (Auckland City Hospital, Auckland, New Zealand)...
Experts react to “compelling” 36-month IN.PACT AV Access trial data
NOTE: This video is ONLY available to watch in selected countries and geographies
Robert Shahverdyan (Hamburg, Germany), Matteo Tozzi (Varese, Italy), Alexandros Mallios (Paris,...
Roundtable: Will latest IN.PACT AV Access data impact practice and can...
NOTE: This video is ONLY available to watch in selected countries and geographies
In this Vascular News roundtable, Andrew Holden (moderator; Auckland, New Zealand) is joined...
Vascular News 94 – June 2022 US Edition
In this issue:
Community-focused approach required to tackle global issue of unnecessary amputations
Perioperative outcomes of carotid endarterectomy not improved on dual versus single...
Vascular News 94 – June 2022 OUS Edition
In this issue:
Community-focused approach required to tackle global issue of unnecessary amputations
Perioperative outcomes of carotid endarterectomy not improved on dual versus single...
First time data release: View the full IN.PACT AV Access trial...
NOTE: This video is ONLY available to watch in selected countries and geographies
In a late-breaking Podium 1st presentation at the 2022 Charing Cross...
CX 2022 highlights new data in the vascular world
Anticipation is building for the Charing Cross International Symposium 2022 (26–28 April, London, UK, in person and virtual), which this year will address some...
More mixed results for DCBs in AV access maintenance as evidence...
Additional randomised controlled data regarding the effectiveness of drug-coated balloons (DCBs) in maintaining arteriovenous (AV) access offers new evidence, but it is freighted with...
Two-year IN.PACT AV Access results presented at CX 2021
Medtronic recently announced the safety and effectiveness results through 24 months for the IN.PACT AV Access clinical study. The data, which were presented virtually...
LINC 2021: Positive first-time data presented for IN.PACT AV DCB and...
New data presented for the first time at LINC 2021 (The Leipzig Interventional Course; 25–29 January, online) support the use of drug-coated balloons (DCBs)...
DCB in dialysis access: Do we finally have the right evidence?
NOTE: This supplement is only available to read in selected countries and geographies
In this supplement, sponsored by Medtronic:
Tobias Steinke outlines his treatment algorithm...
Six-month IN.PACT AV Access results published, show superiority of DCB angioplasty
Just-published six-month results of the IN.PACT AV Access study show that drug-coated balloon (DCB) angioplasty is superior to standard angioplasty for the treatment of...
LINC 2020: Positive new data for AV access interventions released
New arteriovenous (AV) access results were presented at the 2020 Leipzig Interventional Course (LINC; 28–31 January, Leipzig, Germany), including data on percutaneous AV fistula...
Medtronic IN.PACT™ AV DCB, now approved for AV fistula maintenance in...
Watch Andrew Holden (Auckland, New Zealand) present the six-month results of the IN.PACT AV Access trial. The multicentre, prospective, randomised controlled trial shows that treatment...
Medtronic DCB receives US FDA approval to treat arteriovenous fistula lesions
Medtronic today announced US Food and Drug Administration (FDA) approval of the IN.PACT AV drug-coated balloon (DCB), a paclitaxel-coated balloon indicated for the treatment...
VIVA 2019: IN.PACT AV DCB shows “consistent effectiveness performance” in subgroup...
Today Medtronic shared a six-month subgroup analysis from the IN.PACT AV Access trial, which evaluated how the IN.PACT AV DCB—an investigational device not currently...
